Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer.

Berenguer Frances MA, Linares-Galiana I, Cañas Cortés R, Marín I Borrás S, Gutiérrez Miguélez C, Najjari D, Slocker A, Bellobí C, Santacana M, Pané Foix M, Alonso MH, Navarro-Martin A, Comas Antón S, Guedea F.

Brachytherapy. 2019 Nov 2. pii: S1538-4721(19)30587-2. doi: 10.1016/j.brachy.2019.09.009. [Epub ahead of print]

PMID:
31690516
2.

GRP94 promotes brain metastasis by engaging pro-survival autophagy.

Santana-Codina N, Muixí L, Foj R, Sanz-Pamplona R, Badia-Villanueva M, Abramowicz A, Marcé-Grau A, Cosialls AM, Gil J, Archila I, Pedrosa L, Gonzalez J, Aldecoa I, Sierra A.

Neuro Oncol. 2019 Oct 22. pii: noz198. doi: 10.1093/neuonc/noz198. [Epub ahead of print]

PMID:
31637425
3.

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.

Ruiz de Porras V, Bystrup S, Cabrero-de Las Heras S, Musulén E, Palomero L, Alonso MH, Nieto R, Arango D, Moreno V, Queralt C, Manzano JL, Layos L, Bugés C, Martinez-Balibrea E.

Cancers (Basel). 2019 Oct 11;11(10). pii: E1540. doi: 10.3390/cancers11101540.

4.

Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.

Caballero-Díaz D, Bertran E, Peñuelas-Haro I, Moreno-Càceres J, Malfettone A, López-Luque J, Addante A, Herrera B, Sánchez A, Alay A, Solé X, Serrano T, Ramos E, Fabregat I.

J Hepatol. 2019 Sep 25. pii: S0168-8278(19)30549-5. doi: 10.1016/j.jhep.2019.09.012. [Epub ahead of print]

5.

Statin use and the risk of colorectal cancer in a population-based electronic health records study.

Ibáñez-Sanz G, Guinó E, Pontes C, Quijada-Manuitt MÁ, de la Peña-Negro LC, Aragón M, Domínguez M, Rodríguez-Alonso L, Blasco A, García-Rodríguez A, Morros R, Moreno V.

Sci Rep. 2019 Sep 19;9(1):13560. doi: 10.1038/s41598-019-49877-5.

6.

Mendelian randomization analysis rules out disylipidaemia as colorectal cancer cause.

Ibáñez-Sanz G, Díez-Villanueva A, Riera-Ponsati M, Fernández-Villa T, Fernández Navarro P, Bustamante M, Llorca J, Amiano P, Ascunce N, Fernández-Tardón G, Salcedo Bellido I, Salas D, Capelo Álvarez R, Crous-Bou M, Ortega-Valín L, Pérez-Gómez B, Castaño-Vinyals G, Palazuelos C, Altzibar JM, Ardanaz E, Tardón A, Jiménez Moleón JJ, Olmos Juste V, Aragonés N, Pollán M, Kogevinas M, Moreno V.

Sci Rep. 2019 Sep 16;9(1):13407. doi: 10.1038/s41598-019-49880-w.

7.

False-Positive Results in a Population-Based Colorectal Screening Program: Cumulative Risk from 2000 to 2017 with Biennial Screening.

Ibáñez-Sanz G, Garcia M, Milà N, Hubbard RA, Vidal C, Binefa G, Benito L, Moreno V; Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study Working Group.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1909-1916. doi: 10.1158/1055-9965.EPI-18-1368. Epub 2019 Sep 5.

PMID:
31488415
8.

Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer.

Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, Campbell PT, Carlson CS, Chan AT, Chang-Claude J, Chen S, Connolly CM, Easton DF, Feskens EJM, Gallinger S, Giles GG, Gunter MJ, Hampe J, Huyghe JR, Hoffmeister M, Hudson TJ, Jacobs EJ, Jenkins MA, Kampman E, Kang HM, Kühn T, Küry S, Lejbkowicz F, Le Marchand L, Milne RL, Li L, Li CI, Lindblom A, Lindor NM, Martín V, McNeil CE, Melas M, Moreno V, Newcomb PA, Offit K, Pharaoh PDP, Potter JD, Qu C, Riboli E, Rennert G, Sala N, Schafmayer C, Scacheri PC, Schmit SL, Severi G, Slattery ML, Smith JD, Trichopoulou A, Tumino R, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Weinstein SJ, White E, Wolk A, Woods MO, Wu AH, Abeçasis GR, Casey G, Nickerson DA, Gruber SB, Hsu L, Zheng W, Peters U.

Hum Genet. 2019 Jul;138(7):789-791. doi: 10.1007/s00439-019-02030-8.

9.

Communication Channels Used by Women to Contact a Population-Based Breast Cancer Screening Program in Catalonia, Spain.

Travier N, Vidal C, Garcia M, Benito L, Medina P, Moreno V.

J Med Syst. 2019 Jun 24;43(8):244. doi: 10.1007/s10916-019-1382-6.

PMID:
31236712
10.

Dietary Inflammatory Index, Dietary Non-Enzymatic Antioxidant Capacity, and Colorectal and Breast Cancer Risk (MCC-Spain Study).

Obón-Santacana M, Romaguera D, Gracia-Lavedan E, Molinuevo A, Molina-Montes E, Shivappa N, Hebert JR, Tardón A, Castaño-Vinyals G, Moratalla F, Guinó E, Marcos-Gragera R, Azpiri M, Gil L, Olmedo-Requena R, Lozano-Lorca M, Alguacil J, Fernández-Villa T, Martín V, Molina AJ, Ederra M, Moreno-Iribas C, Perez B, Aragonés N, Castello A, Huerta JM, Dierssen-Sotos T, Gómez-Acebo I, Molina-Barceló A, Pollán M, Kogevinas M, Moreno V, Amiano P.

Nutrients. 2019 Jun 21;11(6). pii: E1406. doi: 10.3390/nu11061406.

11.

Lifestyle and dietary environmental factors in colorectal cancer susceptibility.

Murphy N, Moreno V, Hughes DJ, Vodicka L, Vodicka P, Aglago EK, Gunter MJ, Jenab M.

Mol Aspects Med. 2019 Oct;69:2-9. doi: 10.1016/j.mam.2019.06.005. Epub 2019 Jun 28. Review.

PMID:
31233770
12.

NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.

Belhadj S, Quintana I, Mur P, Munoz-Torres PM, Alonso MH, Navarro M, Terradas M, Piñol V, Brunet J, Moreno V, Lázaro C, Capellá G, Valle L.

Sci Rep. 2019 Jun 21;9(1):9020. doi: 10.1038/s41598-019-45281-1.

13.

Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?

Castet F, Garcia-Mulero S, Sanz-Pamplona R, Cuellar A, Casanovas O, Caminal JM, Piulats JM.

Cancers (Basel). 2019 Jun 17;11(6). pii: E834. doi: 10.3390/cancers11060834. Review.

14.

Epstein Barr virus antibody reactivity and gastric cancer: A population-based case-control study.

Aragonés N, Fernández de Larrea N, Pastor-Barriuso R, Michel A, Romero B, Pawlita M, Mayorgas-Torralba S, Martín V, Moreno V, Casabonne D, Castilla J, Fernandez-Tardón G, Dierssen-Sotos T, Capelo R, Salas D, Salcedo-Bellido I, Chirlaque MD, Brenner N, Pedraza M, Bessa X, Pérez-Gómez B, Butt J, Kogevinas M, Del Campo R, de Sanjosé S, Waterboer T, Pollán M.

Cancer Epidemiol. 2019 Aug;61:79-88. doi: 10.1016/j.canep.2019.05.008. Epub 2019 May 30.

PMID:
31154081
15.

Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.

IJsselsteijn ME, Sanz-Pamplona R, Hermitte F, de Miranda NFCC.

Mol Aspects Med. 2019 Oct;69:123-129. doi: 10.1016/j.mam.2019.05.003. Epub 2019 Jun 4. Review.

PMID:
31136750
16.

Flavonoids and the Risk of Gastric Cancer: An Exploratory Case-Control Study in the MCC-Spain Study.

Vitelli Storelli F, Molina AJ, Zamora-Ros R, Fernández-Villa T, Roussou V, Romaguera D, Aragonés N, Obón-Santacana M, Guevara M, Gómez-Acebo I, Fernández-Tardón G, Molina-Barceló A, Olmedo-Requena R, Capelo R, Chirlaque MD, Pérez-Gómez B, Moreno V, Castilla J, Rubín-García M, Pollán M, Kogevinas M, Lera JPB, Martín V.

Nutrients. 2019 Apr 27;11(5). pii: E967. doi: 10.3390/nu11050967.

17.

Whole-genome sequence analysis of a Pan African set of samples reveals archaic gene flow from an extinct basal population of modern humans into sub-Saharan populations.

Lorente-Galdos B, Lao O, Serra-Vidal G, Santpere G, Kuderna LFK, Arauna LR, Fadhlaoui-Zid K, Pimenoff VN, Soodyall H, Zalloua P, Marques-Bonet T, Comas D.

Genome Biol. 2019 Apr 26;20(1):77. doi: 10.1186/s13059-019-1684-5.

18.

Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.

Guillén Díaz-Maroto N, Sanz-Pamplona R, Berdiel-Acer M, Cimas FJ, García E, Gonçalves-Ribeiro S, Albert N, Garcia-Vicién G, Capella G, Moreno V, Salazar R, Villanueva A, Molleví DG.

Clin Cancer Res. 2019 Jul 15;25(14):4466-4479. doi: 10.1158/1078-0432.CCR-18-3957. Epub 2019 Apr 12.

PMID:
30979739
19.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Pertesi M, Vallée M, Wei X, Revuelta MV, Galia P, Demangel D, Oliver J, Foll M, Chen S, Perrial E, Garderet L, Corre J, Leleu X, Boyle EM, Decaux O, Rodon P, Kolb B, Slama B, Mineur P, Voog E, Le Bris C, Fontan J, Maigre M, Beaumont M, Azais I, Sobol H, Vignon M, Royer B, Perrot A, Fuzibet JG, Dorvaux V, Anglaret B, Cony-Makhoul P, Berthou C, Desquesnes F, Pegourie B, Leyvraz S, Mosser L, Frenkiel N, Augeul-Meunier K, Leduc I, Leyronnas C, Voillat L, Casassus P, Mathiot C, Cheron N, Paubelle E, Moreau P, Bignon YJ, Joly B, Bourquard P, Caillot D, Naman H, Rigaudeau S, Marit G, Macro M, Lambrecht I, Cliquennois M, Vincent L, Helias P, Avet-Loiseau H, Moreno V, Reis RM, Varkonyi J, Kruszewski M, Vangsted AJ, Jurczyszyn A, Zaucha JM, Sainz J, Krawczyk-Kulis M, Wątek M, Pelosini M, Iskierka-Jażdżewska E, Grząśko N, Martinez-Lopez J, Jerez A, Campa D, Buda G, Lesueur F, Dudziński M, García-Sanz R, Nagler A, Rymko M, Jamroziak K, Butrym A, Canzian F, Obazee O, Nilsson B, Klein RJ, Lipkin SM, McKay JD, Dumontet C.

Leukemia. 2019 Sep;33(9):2324-2330. doi: 10.1038/s41375-019-0452-6. Epub 2019 Apr 9. No abstract available.

20.

AKT1low quiescent cancer cells in ductal carcinoma in situ of the breast.

Kabraji S, Sole X, Huang Y, Bango C, Sgroi D, Loda M, Ramaswamy S.

NPJ Breast Cancer. 2019 Mar 21;5:10. doi: 10.1038/s41523-019-0105-y. eCollection 2019.

Supplemental Content

Loading ...
Support Center